|
Summary Information: Aptevo Therapeutics Inc. Common Stock NASDAQ:APVO |
  [email protected] |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies for the treatment of cancer. The Company's lead clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed based on the Company's versatile and robust ADAPTIR™ modular protein technology platform. The ADAPTIR™ platform is capable of generating highly differentiated bispecific antibodies with unique mechanisms of action for the treatment of different types of cancer.
__The following are links to various summary and news pages for __Aptevo Therapeutics Inc. Common Stock [ APVO ]. __Note: Some Links might not have information for the company. |
|